6 Einträge gefunden

1. Secukinumab 2-weekly vs. 4-weekly dosing in patients with plaque-type psoriasis: results from the randomized GAIN study

   1. Reich, K
   2. Körber, A
   3. Mrowietz, U
   4. Sticherling, M
   5. Sieder, C
   6. Früh, J
   7. Bachhuber, T

   2021 - Forschungsinformationssystem des UKE
2. Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study

   1. Thaçi, D
   2. Körber, A
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Duetting, E

   2020 - Forschungsinformationssystem des UKE
3. Prevalence, predictors and comorbidity of dry skin in the general population

   1. Augustin, M
   2. Kirsten, N
   3. Körber, A
   4. Wilsmann-Theis, D
   5. Itschert, G
   6. Staubach-Renz, P
   7. Maul, J-T

   2019 - Forschungsinformationssystem des UKE
4. Definition of psoriasis severity in routine clinical care: current guidelines fail to capture the complexity of long-term psoriasis management

   1. Augustin, M
   2. Langenbruch, A
   3. Gutknecht, M
   4. Reich, K
   5. Körber, A
   6. Maaßen, D
   7. Mrowietz, U

   2018 - Forschungsinformationssystem des UKE
5. Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

   1. Körber, A
   2. Thaçi, D
   3. von Kiedrowski, R
   4. Bachhuber, T
   5. Melzer, N
   6. Kasparek, T
   7. Kraehn-Senftleben, G

   2018 - Forschungsinformationssystem des UKE
6. The genetic basis for most patients with pustular skin disease remains elusive

   1. Mössner, R
   2. Wilsmann-Theis, D
   3. Oji, V
   4. Gkogkolou, P
   5. Löhr, S
   6. Schulz, P
   7. Körber, A

   2018 - Forschungsinformationssystem des UKE